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TRIAGE AND EMERGENCY MEDICAL MANAGEMENT  
OF THE ACUTE RADIATION SYNDROME
Arkadiusz Trzos 1,2, Wiktoria Kudła 3, Karol Łyziński 1,4
Introduction: Medical personnel of the state Emergency Medical Services (EMS) will be the first element involved 
in providing assistance to victims of radiation incidents. Triage, initial diagnosis and further patient medical manage-
ment will depend on their actions. In many radiation incidents, initial radiation triage and early diagnostics will be 
carried out in the emergency department (ED) or trauma center (TC). Extended triage, diagnosis of ARS and proper 
treatment will be continued in specialist centers.
The aim: To present a model of patient medical management including initial triage and early diagnosis of ARS that 
can be carried out at the ED and TC.
Material and methods: The initial medical procedures prepared by expert groups were presented. The choice of 
procedures was made in terms of the possibility of their application by the EMS teams in Poland. Particular attention 
was paid to the method of initial triage, based on the clinical condition and laboratory diagnostics.
Results: Based on the material collected, the path of the initial medical procedure was presented. Variants of the 
radiation triage, interpretation of clinical parameters and results of laboratory tests are presented. The methods of 
initial treatment and the method of qualification for specialist treatment, and new methods of treating patients were 
also described.
Conclusions: An adequate evaluation of radiation incidents, determining the absorbed dose of ionising radiation and 
ARS, as well as initial triage seem to be crucial skills of the EMS workers. 
INTRODUCTION
A radiation incident is any event occurring in Po-
land and abroad involving the use of nuclear materials, 
ionising radiation sources, radioactive waste products 
or any other radioactive substances which result in or 
have the potential to result in a radiation emergency in 
which ionising radiation threshold doses, specified in 
the applicable regulations, might have been exceeded, 
and hence certain emergency medical procedures may 
be required to maintain safety of workers and the gen-
eral public [1]. Emergency procedures in the event of 
a radiation emergency are subject to the regulation of 
18 January 2005 on emergency procedure plans in a 
radiological emergency [2]. 
Health effects of absorbed radiation may be the 
result of external exposure to radiation that may be 
combined with external contamination with radioac-
tive substances; or internal contamination resulting 
from absorption of radioactive isotopes through inha-
lation of radioactive dust, swallowing contaminated 
food products or water or through skin involving 
direct handling of contaminated material (skin con-
tamination). Those three modes of exposure to radia-
tion may occur together and may be combined with 
other traumas e.g. thermal, mechanical from a blow. 
A type of exposure to ionising radiation may deter-
mine emergency medical management and priorities 
of procedures. In the event of radioactive contamina-
tion or any assumption that such contamination might 
have occurred, decontamination procedures shall be 
started to prevent further radiation [3]. The absorbed 
dose greater than 1 Gy in case of whole-body or 
high-dose significant partial-body exposure to radia-
tion results in the acute radiation syndrome (ARS) 
[4]. In case of subthreshold doses, changes in short-
termed peripheral blood values may be noted. Doses 
greater than 10 Gy are considered to be mainly lethal 
[5]. In the event of exposure to doses larger than 10 
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Gy, the bone marrow failure is of minor importance 
for survival in patients as their survival is dependant 
on the damages to organs other than the bone mar-
row such as the lungs, gastrointestinal tract, and cutis 
since these patients tend to suffer fatal multi-organ 
failure (MOF) even though the bone marrow aplasia 
has been successfully managed. Recent data suggests 
that the average lethal dose of radiation to the whole 
body that will kill 50% of the exposed population 
within 60 days (LD50/60) ranges between 3.25 Gy 
and 4 Gy for patients without supportive treatment 
and 6-7 Gy for patients treated with antibiotics and 
transfusion [7]. A concentrated radiation dose may 
lead to cutaneous radiation syndrome (CRS) without 
the probability of developing MOF. Beta radiation 
and low-energy X-ray do not penetrate deep in tissue 
and induce only cutaneous injuries without any dam-
age to the internal organs [8, 9].
The management of radiation emergencies used 
so far has been mainly focused on providing medical 
treatment to individual casualties or a minor group 
of casualties in places where radiation sources were 
used, thus the radiation emergency was expected. 
Moreover, adopted medical procedures have re-
sponded only to radiation-induced injuries exclud-
ing the impact of other traumas, mostly mechanical 
ones (post-explosion injuries). The end of the cold 
war has not limited the radiation threat. In recent 
years the total amount of scattered radiation mate-
rial has increased globally. The situation is caused 
by temporary loss of control over nuclear materials 
and their uncontrolled distribution, and partly due to 
an increased ability and apparent readiness of terror-
ists and criminal groups to use nuclear materials for 
their own purposes. The use of radioactive materi-
als in “dirty bombs” or constructing and detonating 
an improvised nuclear device have become common 
terrorist attack scenarios. Computer simulations of 
nuclear attacks allow to estimate the number of civil 
casualties [10, 11]. For instance, it is estimated that 
more than 500 000 people would be in a damage zone 
within 2 hours from a 10 kT nuclear detonation in 
Los Angeles (California, USA) [12]. The prospects 
of massive human losses are changing medical re-
sponders’ approach regarding the management of 
rescue actions performed during radiation emergen-
cies. Therefore, the experience of military medicine 
is more often taken into consideration. 
In case of radiation emergency the national EMS 
teams are to be involved in the management of rescue 
actions on both pre-hospital and early hospital stages 
(emergency rooms, trauma centres). Consequently, 
the EMS shall take on the responsibility for relevant 
diagnosis and initial care provided to the injured in 
the radiation incident. Further diagnosis and special-
ist care are provided in specialist care centres. The 
authors of this paper, being aware of the complex 
nature of medical care management in case of radia-
tion incidents, have focused on triage, diagnostics 
and procedures that are employed during the rescue 
actions performed by EMS teams to the patients ex-
posed to large doses of radiation.
TRIAGE
Initial responses of rescue teams in terms of radia-
tion incidents involve assessing medical condition of 
casualties (triage). Furthermore, certain patients will 
receive priority intervention at subsequent levels of 
care. Initial triage based on the ABCD approach ena-
bles to decide whether injuries are life-threatening 
and require an immediate medical intervention. Pa-
tients with potentially life-threatening injuries must 
be primarily treated, and then decontaminated [13]. 
Once the vital functions are stable, EMS may proceed 
to triage and radiation diagnostics. Radiation triage 
guidelines differ from the model commonly used by 
the EMS teams on a daily basis. Moreover, depend-
ing on the scale of an incident, and the number of 
casualties and the efficiency of emergency services 
in particular, the interpretation of the results of tri-
age scores may be altered. Radiation triage includes 
assessing, monitoring symptoms of each ARS stage 
(prodromal, latent, manifest illness and recovery or 
death) and calculating the absorbed dose. Samples of 
tissue are drawn and biometric tests are carried out in 
order to determine the absorbed dose. Combined-in-
jury casualties (combined traumas) with both radia-
tion and mechanical traumas need to undergo trauma 
and radiation triage, and thus relevant modification 
of the results may be required (Table 1).
For the purposes of triage and early diagnostics, 
methods of clinical assessment and laboratory tests 
may be employed simultaneously. 
CLINICAL EVALUATION
Initial radiation triage of the patient especially in 
terms of mass incidents may be based on the evalua-
tion of prodromal stage. The onset of symptoms after 
the exposure, the intensity and severity of prodromal 
symptoms shall allow to estimate the absorbed dose. 
Table 2 presents parameters and interpretation of re-
sults in this particular evaluation method in detail. 
The onset of radiation-induced vomiting and its 
severity is the most indicative parameter for the as-
sessment of a patient’s condition [14]. Other param-
eters are of lesser importance to assess the severity of 
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the radiation injuries. Body temperature above 37oC 
within 5 hours after the exposure to radiation indi-
cates the dose of ≥2,5 Gy [15]. The occurrence of 
early erythema within 6 hours after the exposure may 
precede the development of the cutaneous radiation 
syndrome (CRS) [16]. A different model of clinical 
evaluation is the scoring triage system METREPOL 
to assess radiation damage to vital organ systems of 
patients suffering from the ARS: neurovascular (N), 
hematopoietic (H), cutaneous (C) and gastrointesti-
nal (G). The evaluation of a damaged organ includes 
symptoms typical for certain damages. Scoring of 
the patients done by organs reflects damages to or-
gan systems and indicates the most affected ones 
and potential risks they carry and the best choice for 
treatment of individuals (Table 3). Each symptom is 
scored from 1 to 4 according to its degree of sever-
ity. A score of 1 implies mild damages while 4 fatal 
ones. A score of 0 in this protocol means there are no 
symptoms observed. Having determined (i - degree 
of severity) the organ specific grading (Ni, Hi, Ci, 
Gi), the response category is established (RC=?xd) 
and measured in days (xd) after exposure. The above 
classification enables the analysis of changes ob-
served in an individual patient and allows to draw a 
comparison of medical conditions between patients 
(Fig. 1) [17].
The application of grading codes improves com-
munication between specialists, facilitates national 
and international communication and interdiscipli-
nary expertise. Coding improves the management of 
treatment and accurate allocation of the injured. 
LABORATORY DIAGNOSTICS 
The contemporary ARS diagnostics consists of 
both observing a patient and specialised diagnostic 
testing [18]. All persons involved in a radiation in-
cident that have been exposed to ionising radiation 
should be examined with the use of a biodosimetry 
during the first 48 hours after the exposure [19]. In 
the first place a complete blood count (CBC) should 
be carried out. A CBC should be repeated every 4 
hours during the first 8 hours following the exposure 
and every 6 hours for the next 40 - 48 hours. A CBC 
analysis is done with special attention to lymphocyte 
counts which is the easiest and fastest laboratory di-
agnostic tool to assess the absorbed dose [18]. Lym-
phocyte depletion is to be observed within 6-24 hours 
following the exposure [20]. A CBC analysis done 
after 2 weeks following the exposure has shown leu-
kopenia, lymphopenia and thrombocytopenia. There-
after, anaemia is observed as well [31]. Lymphocyte 
depletion rate may suggest the irradiation symptoms 
in patients who are unaware of having been exposed 
to ionising radiation. Another solution to be used 
while denoting the exposure is checking the levels of 
serum amylase. It has been indicated that any radia-
tion dose greater than 0,5 Gy increases the levels of 
amylase in blood [21]. Although the level of amylase 
may increase in other clinical situations, it is worth 
mentioning that the increase in amylase especially in 
its salivary fraction may suggest the exposure to ra-
diation [22]. 
The gold standard for diagnosing ARS is dosim-
etry of chromosomal aberration in circulating blood 
lymphocytes. Biological dosimetry enables to calcu-
late the absorbed dose based on the analysis of the 
radiation damages observed in irradiated cells i.e. 
the effects of radiation. 6 dicentric chromosomes in 
1 000 cells have been observed after radiation of 0.1 
Gy. The dicentric chromosome assay (DCA) is em-
ployed in case of the exposure with doses of range 
of 0.1 to 5-6 Gy [23]. The cell division is blocked 
above this range; thus, this method is found useless 
for higher doses. Another example of mutations at 
a molecular level are micronuclei. Micronuclei are 
not as sensitive to radiation as dicentrics. The detec-
tion level is 0.3 Gy. The frequency of the occurrence 
of micronuclei is directly proportional to the radia-
tion dose. Moreover, due to radiation, chromosomal 
translocations are present. 4 - 12 spontaneous translo-
cations in 1 000 cells have been detected with a dose 
of range 0.5 - 5 Gy. It is possible to observe due to 
a fluorescent in situ hybridization (FISH) technique, 
which uses molecular probes to visualise specific 
DNA sequences. An entire chromosome or fragments 
of chromatin near centromeres of individual chromo-
somes have been analysed. With doses greater than 
5 - 6 Gy it is crucial to detect premature chromosome 
condensation (PCC). The evaluation of dicentric 
chromosomes is proved unreliable with higher doses 
of radiation while PCC is dose-independent so there 
are no restrictions [24]. 
TREATMENT MANAGEMENT
Appropriate medical interventions following the 
radiation exposure at both pre-hospital and early hos-
pital stages (emergency rooms, trauma centres) in-
volve interviewing the patient, physical examination, 
running additional tests, and based on their results 
estimating the absorbed dose and introducing symp-
tomatic treatment [25]. Treatment in the prodromal 
phase focuses on administering antiemetics, antidiar-
rheals, analgesics, blood transfusion or blood prod-
ucts [26,27]. 5HT-3 receptor antagonists are most 
effective for vomiting. According to the Radiation 
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Emergency Assistance Center/Training Site ondanse-
tron, granisetron can be utilized for the treatment and 
only alosetron is not recommended for gastrointes-
tinal syndrome because it is associated with colonic 
ischaemia [28]. Anticholinergics or loperamid can 
be used to treat diarrhoea of patients exposed to ra-
diation [29]. Patients suffering from headaches being 
the result of radiation should receive widely available 
painkillers. Acetylsalicylic acid must be given with 
caution due to a greater risk of bleeding [30]. Any 
blood products that are given to a patient must be 
leukoreduced and irradiated with a dose of 25 Gy to 
prevent transfusion-associated graft-versus-host re-
action [31,32]. It is advised to treat with granulocyte 
macrophage colony-stimulating factor (GM-CSF), 
granulocyte colony-stimulating factor (G-CSF), and 
the pegylated form of G-CSF when radiation doses 
are from 5 to 10 Gy. Patients should be treated with 
CSFs in the first 24 hours to become effective [13]. 
Patients with ARS are treated with cytokines such as 
filgrastim (G-CSF), sargramostim(GM-CSF), pegfil-
grastim (pegG-CSFC) [33]. Cytokine therapy should 
be continued for 2-3 weeks following the exposure or 
until an absolute neutrophil count equals >1000µL. 
Interleukin (IL)-12 is also used besides GM-CSF. IL-
12 stimulates megakaryocyte growth and unlike cy-
tokines improves patients’ survival after irradiation 
[34]. In irradiated patients with doses greater than 10 
Gy administering cytokine therapy is doubtful due to 
possible lack of stem-progenitor cells. Those patients 
require a bone marrow stem cell transplantation [4]. 
New solutions are being constantly searched for to 
treat ARS even more effectively. Lots of tests have 
been carried out on animals to get a new perspective 
on treating ARS. Entolimod/CBLB52 acts as an ago-
nist of toll-like receptor 5 (TLR5). Tests on animal 
models proved entomolid to lead to a significant im-
provement in animal survival and neutropenia after 
exposure with lethal doses of radiation [35]. AEOL 
10150 (metalloporphyrin mimetic) acts as an antioxi-
dant and is administered to the patients with acute, 
radiation-induced lungs injury. The results of one pi-
lot study have indicated that treatment with AEOL 
1050 results in reduced clinical, radiographic, ana-
tomic, and molecular evidence of radiation-induced 
lung injury [36]. 5-androstenediol (AED) is admin-
istered with doses of 4-6 Gy and is observed to im-
prove a CBC especially platelets so it becomes use-
ful to treat acute hematopoietic radiation syndrome 
[37]. When salivary glands get irradiated causing dry 
mouth and reduced saliva production, amifostine is 
used [38]. An increased risk of bleeding and blood 
loss in irradiated individuals require blood platelets 
transfusion, which is the only available medical in-
tervention to treat thrombocytopenia. Several factors 
are considered such as interleukin-11, thrombopoi-
etin TPO, romiplostim (a peptide TPO mimetic that 
binds and activates the TPO-receptor) and eltrom-
bopag (a non-peptide that binds to a transmembrane 
site on the TPO-receptor) [33]. It is recommended to 
have platelets maintained at ≥20 000/L in irradiated 
individuals [39]. 
SUPPORTIVE THERAPY 
In the event of radiation incidents, supportive care 
should include the administration of antimicrobial 
agents. The risk of infections is high due to a low 
number of lymphocytes and neutrophils in the blood 
and skin barrier and mucous membrane disruptions, 
which works as a physical barrier to protect from 
germs. Since immune functions may be impaired, a 
sanitary regime is highly required in order to prevent 
transmission of pathogens. The intensity of infec-
tions in patients with ARS depends on the virulence 
of infectious agents, humoral and cell-type responses 
and an effective phagocytic function [27]. The use 
of antimicrobial agents depends on the number of 
neutrophils in blood. If the patient’s neutrophil count 
is >500/µl, then therapy with fluoroquinolones (e.g. 
levofloxacin) should be chosen. If the patient’s neu-
trophil count is <500/µl, broad-spectrum intravenous 
antibiotic therapy should be considered. The scheme 
of intravenous antibiotic therapy may be as follows: 
I single-drug therapy: imipenem/cilastatin/meropen-
em/piperacillin/tazobactam/cefepime / ceftazi-
dime
II 2-drug therapy: aminoglycoside/cilastatin + peni-
cillin or aminoglycoside + cephalosporin
III therapy with vancomycin is limited to specific in-
dications for intravenous monotherapy or combi-
nation therapy [40].
Antibiotic therapy should be administered im-
mediately to patients with neutropenic fever. Promi-
nent causes of infections are Gram-positive bacteria 
(incl. methicillin-resistant Staphylococcus and van-
comycin-resistant Enterococcus) and Gram-negative 
bacteria (incl. Pseudomonas aeruginosa, Escherichia 
coli, and Klebsiella species) [40]. 
Immunosuppressed patients exposed to radia-
tion are more susceptible to viral and fungal infec-
tions. Acyclovir for viral infections and flucona-
zole for fungal ones are advised to be administered. 
Cytomegalovirus and opportunistic Pneumocystis 
Jirovecii are considered to be important pathogens 
whose reactivation may be the result of progressive 
radiation-induced immunosuppression [37].
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DISCUSSION
Radiation incidents vary depending on the na-
ture of the event and may pose different threats. 
Patients at the Emergency Department might have 
been exposed to radiation a long time before and 
may have no knowledge of high-dose exposure. 
Patients may bring radioactive materials into hos-
pital when the substance is deposited on their body 
surface or clothing unknowingly. EMS teams may 
be sent to a patient who is in a contaminated envi-
ronment so it is crucial to take radiation risks into 
consideration when assessing safety of performed 
medical interventions. Triage and medical care 
management happens to be complex. The analysis 
of radiation incidents showed that the level of ir-
radiation of casualties injured in the same incident 
may vary depending on the absorbed dose and tissue 
volume exposed to radiation. Radiation exposures 
can involve a small part of the body (e.g. arms), 
larger parts or the whole body. Furthermore, body 
positioning affects the absorbed dose. Certain expo-
sure to the source of radiation may damage or shield 
sensitive organs and biological effects of the same 
dose may be different. The radiation dose may be 
delivered over an extended period of time (repeated 
exposures) or as a single exposure to a high dose 
of radiation. The fact which body part is affected 
by radiation is of greater importance than an overall 
dose of exposure. This variability makes standardi-
zation of triage process, diagnosing and implement-
ing medical treatment extremely difficult. For that 
reason the management of medical responses in ra-
diation events is complex and multi-layered. Once 
an early/initial diagnostic process is performed at 
Emergency Rooms, patients should be distributed 
appropriately for different departments depending 
on the scale of damages to their organs and available 
resources such as well-trained personnel, equipment 
and medication. Patients who are likely to develop 
MOF (RC>3) should be admitted to the intensive 
care unit; patients with severe and extensive radia-
tion skin lesions should be admitted to the burn unit 
and all remaining patients to the haematological cell 
therapy unit. Triage and proper allocation enable an 
effective use of available resources and improve the 
efficacy of medical treatment provided. 
It is crucial for the medical care management to 
decide whether patients have residual hematopoie-
sis, which is common after the radiation incidents 
since some parts of the bone marrow tend to be 
underexposed or protected from accidental radia-
tion. The residual hematopoiesis significantly influ-
ences a decision-making process of medical teams 
as hematopoietic stem cell (HSC) transplantation, 
despite the absorbed dose being high, may be un-
necessary. HSC transplantation should not be per-
formed on radiation incident casualties who have 
the potential of endogenous hematopoietic recov-
ery. Radiation-induced casualties are not advised 
to have hematopoietic stem cells transplanted due 
to patients’ potential of endogenous hematopoietic 
recovery. Therefore, emergency HSC transplan-
tation is not necessary in every accidental whole-
body irradiation. However, if severe aplasia persists 
in spite of cytokine treatment for more than 14-21 
days, HSC transplantation should be considered. 
However, in situations where high doses have been 
delivered, the damage to the bone marrow becomes 
less relevant and the prognosis of these patients de-
pends on the extent of the damage to organs other 
than the bone marrow sc. the lungs, gastrointestinal 
tract, and skin. These patients have a greater risk 
of developing fatal multi-organ failure MOF, even 
if the bone marrow aplasia has been successfully 
managed. Supportive care should include protective 
isolation (reverse barrier nursing) but that requires 
an adequate infrastructure and may involve interna-
tional cooperation. Supportive therapy and specific 
therapeutic approaches are required in every case. 
However, the circumstances change radically in the 
event of radiation disasters, intentional releases of 
radiological materials on a mass scale, and the use 
of a nuclear weapon (armed conflicts and terrorist 
attacks) and the above-mentioned management of 
triage and medical treatment becomes invalid. 
CONCLUSIONS
Initial emergency procedures with patients ex-
posed to high doses of ionising radiation involve 
various EMS resources. Radiation triage is an indis-
pensable part of medical care management in case 
of radiation incidents. Early rescue procedures/inter-
ventions are as follows: detecting radiation, assess-
ing the radiation doses and their health effects on an 
individual’s body incl. developing ARS. Type of ex-
posure, the radiation-absorbed dose, additional trau-
matic injuries determine the organization of medical 
responses. The organ specific grading to assess prog-
nostic aspects of ARS (grading codes: Ni, Ci, Gi, Hi, 
RC) enables and enhances communication and coop-
eration between centres in the country and abroad. 
The increasing risk of radiation events necessitates 
the management of medical care based on effective 
triage that is a crucial skill of EMS teams. 
1. Triage category depends on the nature and extent 
of physical injury.
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2. Although other injuries may be minimal, treat-
ment guidelines should be followed for patients 
receiving a whole-body radiation dose greater 
than 3 Gy. 
3. The „expectant” category applies to patients who 
have no signs of life or suffered fatal injuries with 
low chances of survival.
Table: 1. Dose-depending triage categories for patients with and without combined injuries.
Conventional triage categories 
for injuries without exposure to 
radiation
Changes in triage categories after whole-body irradiation
 <1,5 Gy 1,5–4,5 Gy 4,5 Gy-10 Gy
Delayed Delayed Variable 1 Expectant 
Immediate Immediate Immediate Expectant
Minimal Minimal Minimal 2 Minimal 2 
Expectant 3 Expectant Expectant Expectant 
Absent Ambulatory monitoring Ambulatory monitoring with routine care and hospitalization as needed
Source: Based on source [41].The military triage system was modified to develop priorities for therapy of irradiated patients and 
combined-injury patients. 
Attention: Military triage is associated with a specific tactical situation
Table 2. Assessment of prodromal phase depending on the amount of absorbed dose of ionizing radiation.
Symptoms Mild (1-2Gy) Moderate (2-4 Gy) Severe (4-6 Gy) Very severe (6-8 Gy) Lethal (> 8 Gy)
Vomiting >2h after exposure 1-2 h after exposure
Earlier than 1 h after 
exposure
Earlier than 30 min after 
exposure
Earlier than 10 after 
exposure
Diarrhoea None None Mild Heavy Heavy 
Headache Slight Mild Moderate Severe Severe 
Consciousness Unaffected Unaffected Unaffected May be altered Unconsciousness
Body temperature Normal Increased Fever High Fever High Fever 
Medical response Outpatient observation
Observation in general 
hospital, treatment in 
specialized hospital if 
needed
Treatment in specialized 
hospital




Source: Based on source [23].
Table 3. Overall prognostic aspects of the ARS on the organ specific grading.
Organ system
Grading and severity of damage
1: mild damage 2. moderate damage 3. severe damage 4. serious/fatal damage
N Recovery certain Recovery with possibile deficyt Recovery with severe deficit Recovery most unlikely
H Autologous recovery certain Autologous recovery likely Autologous recovery possible
Autologous recovery most 
unlikely
C Recovery certain Recovery without deficit likely Recovery with deficit likely
Recovery most unlikely or with 
serious deficit
G Recovery certain Recovery with possibile deficit Recovery may be possible Recovery most unlikely
Source: Based on source [30].
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Fig. 1. ARS clinical evaluation. Source: Based on source [30].
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